Indirect insulin resistance detection: Current clinical trends and laboratory limitations
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
31165793
DOI
10.5507/bp.2019.021
Knihovny.cz E-zdroje
- Klíčová slova
- decision limit, insulin resistance, reference interval,
- MeSH
- glukózový toleranční test metody MeSH
- glykemický index MeSH
- homeostáza fyziologie MeSH
- inzulinová rezistence fyziologie MeSH
- krevní glukóza metabolismus MeSH
- lidé MeSH
- referenční hodnoty MeSH
- sekrece inzulinu fyziologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- krevní glukóza MeSH
There is a steady increase in the number of overweight and obese people worldwide and increasingly, younger people. Excess adipose tissue impairs the action of insulin, leading to insulin resistance (IR). Tissue IR is a major factor in relation to cardiovascular disease, metabolic syndrome and diabetes. Thus, it is important to recognize at the pre-disease stage with the possibility of therapeutic intervention. IR is assessed using indicators of epidemiological significance, most often calculated from fasting and postprandial glucose and insulin values, so-called indirect indicators of insulin resistance. The most commonly used parameter is the Homeostatic Model Assessment (HOMA). Although the Quantitative Insulin Sensitivity Check Index (QUICKI), Matsuda Index and the Insulin Secretion-Sensitivity Index-2 (ISSI-2) are also used, the values of these indices established for IR vary for different age, sex, populations and ethnic groups. Thus, appropriate reference values of indirect indices should be determined for such groups, and when this is precluded, data from published studies carried out on the most ethnically, socio-economically and age-matched populations should be applied.
Citace poskytuje Crossref.org